Further, little research has been reported describing the role of TNFA signaling in BPDCN, though studies have shown increased TNFA signaling in the plasma of patients with acute myeloid leukemia (47, 48). This evidence concerns the gene TNF and CD4+/CD56+ hematodermic neoplasm.